Chicago, June 28, 2024 (GLOBE NEWSWIRE) -- The global flow cytometry market, valued at $5.1 billion in 2024, is projected to grow to $10.3 billion by 2032, with a compound annual growth rate (CAGR) of 9.2%. This growth is driven by technological advancements enhancing workflow efficiency and data analysis capabilities. Key factors include increased adoption in clinical diagnostics, rising prevalence of chronic diseases, and expanding biopharmaceutical research. However, high instrument costs pose a challenge, particularly for smaller facilities. Opportunities lie in the market's expansion in clinical applications, supported by advancements in reagents and increasing recognition in precision medicine. North America currently dominates the market due to robust healthcare infrastructure and substantial R&D investment, while the Asia Pacific region shows significant growth potential driven by rising healthcare expenditure and supportive government initiatives. Major players include Becton, Dickinson and Company, Danaher Corporation, and Thermo Fisher Scientific Inc., among others, actively developing advanced flow cytometry technologies.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584
Dominance of Cell-Based Technology and Research Applications Fuels Flow Cytometry Market Growth
The flow cytometry market, categorized into cell-based and bead-based technologies, sees cell-based flow cytometry maintaining its dominance, driven by applications in immunology, cancer research, and clinical diagnostics. In 2023, the reagents and consumables segment held a significant market share, influenced by its critical role in drug discovery and life sciences research investments. Research applications lead in market share and are expected to grow substantially, supported by advancements in analytical tools and increased adoption of sophisticated instruments.
Academic and Research Institutes Lead Flow Cytometry Market Growth, Asia Pacific Shows Highest Potential
In the flow cytometry market, academic and research institutes were the dominant end users in 2023, expected to grow significantly through the forecast period. This segment benefits from continuous funding and collaborations, driving demand for advanced flow cytometers. Geographically, North America held the largest market share in 2023 due to robust research funding and advanced healthcare infrastructure. Meanwhile, the Asia Pacific region is poised for accelerated growth, fueled by investments in healthcare, expanding research activities, and a burgeoning biotech sector, supported by the adoption of advanced diagnostic technologies.
Key Players Drive Innovation in the Competitive Flow Cytometry Market
Leading companies such as BD, Danaher Corporation, Thermo Fisher Scientific, and Agilent Technologies play pivotal roles in the flow cytometry market through strategic initiatives like product launches and acquisitions. These efforts bolster their market presence amid increasing competition and technological advancements in the field.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584
BD Leads Flow Cytometry Market with Innovation and Global Expansion Strategies
Becton, Dickinson and Company (BD) dominates the flow cytometry market through strategic acquisitions, continuous innovation, and robust R&D investments. BD's launch of the BD FACSDiscover S8 Cell Sorter in March 2023, the first spectral cell sorter with high-speed imaging, underscores its technological leadership and customer-centric approach.
Danaher Corporation Drives Flow Cytometry Market Growth Through Acquisitions and Technological Advancements
Danaher Corporation excels in the flow cytometry market with strategic acquisitions, including Beckman Coulter and Cytiva, enhancing their product portfolio. Their focus on user-centric design and technological innovation, such as the CytoFLEX nano Flow Cytometer launched in March 2024, solidifies their position in providing cutting-edge flow cytometry solutions.
Thermo Fisher Scientific Innovates and Expands Global Footprint in Flow Cytometry Market
Thermo Fisher Scientific maintains a strong presence in the flow cytometry market through a diversified product portfolio and global distribution network. Their emphasis on R&D and partnerships with academic institutions, exemplified by products like the Attune NxT Flow Cytometer, underscores their commitment to advancing flow cytometry technology and meeting customer demands.
For More information, Inquire Now.
Related Reports:
Infectious Disease Diagnostics Market
Get access to the latest updates on Flow Cytometry Companies and Flow Cytometry Market Share
